by Barry | Oct 3, 2022 | Press Releases
CORALVILLE, IA / October 3, 2022 / Viewpoint Molecular Targeting, Inc. (“Viewpoint” or the “Company”), a radiopharmaceutical company developing precision lead-212-based α-particle oncology therapeutics and complementary diagnostic imaging...
by Barry | Sep 29, 2022 | Press Releases
CORALVILLE, IA / September 29, 2022 / Viewpoint Molecular Targeting, Inc. (“Viewpoint” or the “Company”), a radiopharmaceutical company developing precision lead-212-based α-particle oncology therapeutics and complementary diagnostic...
by Barry | Feb 22, 2022 | Press Releases
Fireside chat with newly appointed CEO, Thijs Spoor, today, February 22 at 1:30 PM ETCORALVILLE, IA / February 22, 2022 / Viewpoint Molecular Targeting, Inc. (“Viewpoint” or the “Company”), a precision oncology company developing alpha-particle...
by Barry | Feb 22, 2022 | Press Releases
Established leader with nearly 30 years of combined executive, broad management and capital markets expertise across healthcare and medical device industriesCORALVILLE, IA / February 22, 2022 / Viewpoint Molecular Targeting, Inc. (“Viewpoint” or the...
by Barry | Jan 20, 2022 | Press Releases
– Live video webcast presentation on Tuesday, January 25th at 11:00 AM ETCORALVILLE, IA / January 20, 2022 / Viewpoint Molecular Targeting, Inc. (“Viewpoint” or the “Company”), a radiopharmaceutical company developing precision...
Recent Comments